4//SEC Filing
Lubman Ellen 4
Accession 0000899243-22-002198
CIK 0001785530other
Filed
Jan 17, 7:00 PM ET
Accepted
Jan 18, 6:30 PM ET
Size
5.6 KB
Accession
0000899243-22-002198
Insider Transaction Report
Form 4
Lubman Ellen
Chief Business Officer
Transactions
- Award
Stock Option (right to buy)
2022-01-06+51,088→ 51,088 totalExercise: $11.55Exp: 2032-01-05→ Common Stock (51,088 underlying)
Footnotes (1)
- [F1]The option was granted on January 6, 2022 with a Vesting Commencement Date of January 1, 2022. The shares underlying the option vest over four years, with 25% of the shares vesting on the first anniversary of the Vesting Commencement Date and 2.0833% of the shares vesting each month thereafter through January 1, 2026.
Documents
Issuer
Werewolf Therapeutics, Inc.
CIK 0001785530
Entity typeother
Related Parties
1- filerCIK 0001857842
Filing Metadata
- Form type
- 4
- Filed
- Jan 17, 7:00 PM ET
- Accepted
- Jan 18, 6:30 PM ET
- Size
- 5.6 KB